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CHAPTER-I 
1. INTRODUCTION 
1.1 Diabetes Mellitus (DM) 
           The Diabetes Mellitus is chronic metabolic disorder, which there are 
high blood sugar level over a prolonged period. The term "mellitus" or "from honey" 
was added by the Briton John Rolle in the late 1700s to separate the condition 
from diabetes insipidus, which is also associated with frequent urination. It is a fast-
growing global problem with huge social, health and economic consequences. It is 
estimated that in 2010 there were globally 285 millions people (approximately 6.4% 
of the adult population) suffering from this disease. This number is estimated to 
increase to 430 million in the absence of better control or cure. An ageing population 
and obesity are two main reasons for the increase. Furthermore it has been shown 
that almost 50% of the putative diabetics are not diagnosed until 10 years after onset 
of the disease, hence the real prevalence of global diabetes must be astronomically 
high.  
This high blood sugar produces the symptoms of frequent urination, increased thirst, 
and increased hunger. Untreated, diabetes can cause many 
complications. Acute complications include diabetic ketoacidosis and non ketotic 
hyperosmolarcoma. Serious long-term complications include heart disease, stroke, 
kidney failure, foot ulcers and damage to the eyes.  
Indian physicians around the same time identified the disease and classified it 
as Madhumeha or "honey urine", noting but the urine would attract ants. This is 
possibly due to the diet and life-style of the ancient people, or because the clinical 
symptoms were observed during the advanced stage of the disease. Galen named 
the disease "Diarrhea of the urine" (diarrhea urinosa). The earliest surviving work 
with a detailed reference to diabetes is that of Aretaeus of Cappadocia (2nd or early 
3rd century CE). Type 1 and type 2 diabetes were identified as separate conditions 
for the first time by the Indian physicians Sushruta and Charaka in 400-500 CE with 
type 1 associated with youth and type 2 with being overweight. Effective treatment 
was not developed until the early part of the 20th century, when Canadians Frederick 
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Banting and Charles Herbert Best isolated and purified insulin in 1921 and 1922.  
This was followed by the development of the long-acting insulin NPH in the 1940s.  
 
 
1.2 Signs and Symptoms 
Fig No:1- Main Symptoms of Diabetes 
 
1.3 Overview of the most significant symptoms of diabetes 
The classic symptoms of untreated diabetes are weight loss, polyuria (frequent 
urination), polydipsia (increased thirst), and polyphagia (increased hunger). 
Symptoms may develop rapidly (weeks or months) in type 1 diabetes, while they 
usually develop much more slowly and may be subtle or absent in type 2 diabetes. 
Several other signs and symptoms can mark the onset of diabetes, although they are 
not specific to the disease. In addition to the known ones above, they include blurry 
vision, headache, fatigue, slow healing of cuts, and itchy skin. Prolonged high blood 
glucose can cause glucose absorption in the lens of the eye, which leads to changes 
in its shape, resulting in vision changes. A number of skin rashes that can occur in 
diabetes are collectively known as diabetic dermadromes. 
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             People (usually with type 1 diabetes) may also experience episodes 
of diabetic ketoacidosis, a type of metabolic problems characterized by nausea, 
vomiting and abdominal pain, the smell of acetone on the breath, deep breathing 
known as Kussmaul breathing, and in severe cases a decreased level of 
consciousness.  
A rare but equally severe possibility is hyperosmolar nonketotic state, which is more 
common in type 2 diabetes and is mainly the result of dehydration. 
1.4 Complications 
All forms of diabetes increase the risk of long-term complications. These typically 
develop after many years (10–20), but may be the first symptom in those who have 
otherwise not received a diagnosis before that time. 
             The major long-term complications relate to damage to blood vessels. 
Diabetes doubles the risk of cardiovascular disease and about 75% of deaths in 
diabetics are due to coronary artery disease. Other "macrovascular" 
diseases are stroke, and peripheral vascular disease. 
The primary microvascular complications of diabetes include damage to the eyes, 
kidneys, and nerves. Damage to the eyes, known as diabetic retinopathy, is caused 
by damage to the blood vessels in the retina of the eye, and can result in gradual 
vision loss and potentially blindness. Damage to the kidneys, known asdiabetic 
nephropathy, can lead to tissue scarring, urine protein loss, and eventually chronic 
kidney disease, sometimes requiring dialysis or kidney transplant. Damage to the 
nerves of the body, known as diabetic neuropathy, is the most common complication 
of diabetes. The symptoms can include numbness, tingling, pain, and altered pain 
sensation, which can lead to damage to the skin. Diabetes-related foot 
problems (such as diabetic foot ulcers) may occur, and can be difficult to treat, 
occasionally requiring amputation. Additionally, proximal diabetic neuropathy causes 
painful muscle wasting and weakness. 
There is a link between cognitive deficit and diabetes. Compared to those without 
diabetes, those with the disease have a 1.2 to 1.5-fold greater rate of decline in 
cognitive function. 
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1.5 Diagnosis 
Diabetes mellitus is characterized by recurrent or persistent hyperglycemia, and is 
diagnosed by demonstrating any one of the following:  
 Fasting plasma glucose level ≥ 7.0 mmol/l (126 mg/dl) 
 Plasma glucose ≥ 11.1 mmol/l (200 mg/dl) two hours after a 75 g oral glucose 
load as in a glucose tolerance test 
 Symptoms of hyperglycemia and casual plasma glucose ≥ 11.1 mmol/l 
(200 mg/dl) 
 Glycated hemoglobin (Hb A1C) ≥ 6.5%. 
A positive result, in the absence of unequivocal hyperglycemia, should be confirmed 
by a repeat of any of the above methods on a different day. It is preferable to 
measure a fasting glucose level because of the ease of measurement and the 
considerable time commitment of formal glucose tolerance testing, which takes two 
hours to complete and offers no prognostic advantage over the fasting test. 
According to the current definition, two fasting glucose measurements above 
126 mg/dl (7.0 mmol/l) is considered diagnostic for diabetes mellitus. 
Per the World Health Organization people with fasting glucose levels from 6.1 to 
6.9 mmol/l (110 to 125 mg/dl) are considered to have impaired fasting glucose. 
People with plasma glucose at or above 7.8 mmol/l (140 mg/dl), but not over 
11.1 mmol/l (200 mg/dl), two hours after a 75 g oral glucose load are considered to 
haveimpaired glucose tolerance. Of these two prediabetic states, the latter in 
particular is a major risk factor for progression to full-blown diabetes mellitus, as well 
as cardiovascular disease. The American Diabetes Association since 2003 uses a 
slightly different range for impaired fasting glucose of 5.6 to 6.9 mmol/l (100 to 
125 mg/dl).  
Glycated hemoglobin is better than fasting glucose for determining risks of 
cardiovascular disease and death from any cause.  
The rare disease diabetes insipidus has similar symptoms to diabetes mellitus, but 
without disturbances in the sugar metabolism (insipidus means "without taste" in 
Latin) and does not involve the same disease mechanisms. 
 
5 
 
 
 
 
 
 
 
Table No .1  
 
WHO DIABETES DIAGNOSTIC CRITERIA  
Condition 
2 hour 
glucose 
Fasting glucose HbA1c 
Unit mmol/l(mg/dl) mmol/l(mg/dl) % 
Normal <7.8 (<140) <6.1 (<110) <6.0 
Impaired fasting glycaemia  <7.8 (<140) 
≥ 6.1(≥110) & 
<7.0(<126) 
6.0–6.4 
Impaired glucose tolerance ≥7.8 (≥140) <7.0 (<126) 6.0–6.4 
Diabetes mellitus ≥11.1 (≥200) ≥7.0 (≥126) ≥6.5 
1.6 Prevention and Treatment 
There is no known preventive measure for type 1 diabetes. Type 2 diabetes can 
often be prevented by a person being a normal body weight, physical exercise, and 
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following a healthy diet. Dietary changes known to be effective in helping to prevent 
diabetes include a diet rich in whole grains and fiber, and choosing good fats, such 
as polyunsaturated fats found in nuts, vegetable oils, and fish. Limiting sugary 
beverages and eating less red meat and other sources of saturated fatcan also help 
in the prevention of diabetes.  Active smoking is also associated with an increased 
risk of diabetes, so smoking cessation can be an important preventive measure as 
well.  
Diabetes mellitus is a chronic disease, for which there is no known cure except in 
very specific situations. Management concentrates on keeping blood sugar levels as 
close to normal ("euglycemia") as possible, without causing hypoglycemia. This can 
usually be accomplished with diet, exercise, and use of appropriate medications 
(insulin in the case of type 1 diabetes; oral medications, as well as possibly insulin, in 
type 2 diabetes). 
Learning about the disease and actively participating in the treatment is vital for 
people with diabetes, since the complications of diabetes are far less common and 
less severe in people who have well-managed blood sugar levels. The goal of 
treatment is an HbA1C level of 6.5%, but should not be lower than that, and may be 
set higher.  Attention is also paid to other health problems that may accelerate the 
deleterious effects of diabetes. These include smoking, elevated 
cholesterollevels, obesity, high blood pressure, and lack of regular exercise. 
Specialised footwear is widely used to reduce the risk of ulceration, or re-ulceration, 
in at-risk diabetic feet. 
1.7 Lifestyle 
People with diabetes can benefit from education about the disease and treatment, 
good nutrition to achieve a normal body weight, and sensible exercise, with the goal 
of keeping both short-term and long-term blood glucose levels within acceptable 
bounds. In addition, given the associated higher risks of cardiovascular disease, 
lifestyle modifications are recommended to control blood pressure.  
1.8 Medications 
Metformin is generally recommended as a first line treatment for type 2 diabetes, as 
there is good evidence that it decreases mortality. Routine use of aspirin, however, 
has not been found to improve outcomes in uncomplicated diabetes. Angiotensin 
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converting enzyme inhibitors (ACEIs) improve outcomes in those with DM while the 
similar medications angiotensin receptor blockers (ARBs) do not.  
Type 1 diabetes is typically treated with a combinations of regular and NPH insulin, 
or synthetic insulin analogs. When insulin is used in type 2 diabetes, a long-acting 
formulation is usually added initially, while continuing oral medications.  Doses of 
insulin are then increased to effect.  
In those with diabetes some recommend blood pressure levels below 120/80 mmHg; 
however, evidence only supports less than or equal to somewhere between 
140/90 mmHg to 160/100 mmHg.  
1.9 Pancreatic transplantation 
A pancreas transplant is occasionally considered for people with type 1 diabetes who 
have severe complications of their disease, including end stage renal 
diseaserequiring kidney transplantation. 
1.10 Support 
In countries using a general practitioner system, such as the United Kingdom, care 
may take place mainly outside hospitals, with hospital-based specialist care used 
only in case of complications, difficult blood sugar control, or research projects. In 
other circumstances, general practitioners and specialists share care in a team 
approach. Home telehealth support can be an effective management technique. 
1.11 Diets And Exercise Treatment 
Making healthy food choices is very important to help keep your blood glucose 
level under control. People with diabetes don't need to buy or prepare special 
foods. The foods that are best for someone with diabetes are excellent choices 
for everyone: foods that are low in fat, salt, and sugar, and high in fiber, such as 
beans, fruits, vegetables, and whole grains. These foods help you reach and stay 
at a weight that's good for your body. Regular physical activity is important for 
people with diabetes. Being physically active has been shown to improve blood 
glucose levels in older people whose levels are high. Exercise is especially good 
for people with diabetes because it helps control weight, helps insulin work better 
to lower blood glucose, is good for your heart and lungs, gives you more energy,  
Regular physical activity improves insulin resistance and lipid profile (reduction in 
8 
 
triglyceride and increase in high-density lipoprotein (HDL)) and lowers blood 
pressure (although blood pressure will rise during exercise),the metabolic 
benefits in type 2 diabetes are lost within 3-10 days of stopping regular exercise, 
physical activity also protects against the development of type 2 diabetes. 
 
 
1.12 A1C Test 
The A1C test is used to detect type 2 diabetes and prediabetes but is not 
recommended for diagnosis of type 1 diabetes or gestational diabetes. The A1C test 
is a blood test that reflects the average of a person’s blood glucose levels over the 
past 3 months and does not show daily fluctuations. The A1C test is more 
convenient for patients than the traditional glucose tests because it does not require 
fasting and can be performed at any time of the day.The A1C test result is reported 
as a percentage. The higher the percentage, the higher a person’s blood glucose 
levels have been. A normal A1C level is below 5.7 percent.An A1C of 5.7 to 6.4 
percent indicates prediabetes. People diagnosed with prediabetes may be retested 
in 1 year. People with an A1C below 5.7 percent maystill be at risk for diabetes, 
depending on the presence of other characteristics that put them at risk, also known 
as risk factors. People with an A1C above 6.0 percent should be considered at very 
high risk of developing diabetes. A level of 6.5 percent or above means a person has 
diabetes. 
1.13 Herbal drugs 
Allopathic medicines are very costly. In contrast, herbal medicines are very cheap. 
This cost effectiveness makes them all the more alluring.Herbal medicines can be 
brought without prescription and they are available in all most all health stores. Some 
herbs can even be grown at home.For certain ailments, herbal medicines are 
considered to be more effective than allopathic medicines. 
Herbal medicines do not have any side effects, as they are free from chemicals. They 
are also milder than allopathic medicines.The natural detoxification process of the 
body is effectively enhanced by herbal medicines. They can be used to cleanse the 
colon, improve digestion and food absorption. Herbal medicines are also very good in 
boosting the immune system. 
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Herbal medicines are very effective in curing various digestive disorders like colitis, 
indigestion, peptic ulcers, and irregular bowel movements.These types of medicines 
are best for people who are allergic to various types of drugs.Herbal medicines are 
also effective in boosting the mental health.Most of the ailments related to blood 
circulation like high blood pressure, varicose ulcers, and many others can be 
controlled through herbal medicine.Some herbal medicines are very good in reducing 
the cholesterol level in the blood stream. They are also used to treat coronary artery 
diseases.Herbal medicine can be used to reduce weight by regulating appetite. 
CHAPTER-II 
2. REVIEW OF LITERATURE 
 Ososki et al.,(2002)[22] Reported Ethnobotanical literature survey of medicinal 
plants in the Dominican republic used for women’s health condition on the usage of 
Haldina Cordifolia     decotion For uro-genital problems can use as decotion 
preparation of seeds taken orally or wash bath. The field work in the Dominican 
republic revealed that herbs were used to treat many women’s health condition 
including uterine fibrosis, excessive uterine bleeding,endometriosis and hot flushes 
in menopause. 
 Dasgupta et al., (2013)[23] investigated and reported The present on 
Priliminary phytochemical studies of Haldina Cordifolia     about the important 
phytochemicals present in the leaf extract. The preliminary screening showed the 
presence of many phytochemicals such as alkaloids,flavonoids, terpenoids, 
saponoin, fixed oils and fats. High Performance Thin Layer Chromatography analysis 
was carried out with optimized solvent system consisting of ethyl acetate, formic 
acid, glacial acetic acid and water in the ratio of 8:1:1:2. The densitometric scanning 
of the chormatograms of hydroaclcoholic extract showed 7peaks at 254 nm 8 peaks 
at 366 nm. The phytochemicals detected in the present study justify the therapeutic 
uses of the leaves in the traditional medicines.  
 Isaac et al., (2007) [24] conducted histopathological and biochemical studies 
on Short-term administration of an aqueous extract of Haldina Cordifolia     
Integra var. crenata (Andr.)  in a 14-day sub-acute toxicity studies using female 
Sprague-Dawley rats on Haldina Cordifolia     Intergra (Ki) leaf extract for the 
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treatment of ulcers, pain and adenoma of the prostate gland repoted about its 
traditionally use for orally administered multipurpose in Ghana and other parts of the 
world. 
Cruz et al., (2012) [28] evaluated and studied on the topic Phytomedicine: 
International Journal of Phytotherapy & Phytopharmacology about Aqueous extract 
of Haldina Cordifolia     Pinnata (Kp) have been found effective in models to reduce 
acute anaphylactic reactions.They investigated on the effect of Kp and the flavonoid 
quercetin (QE) and quercitrin (QI) on mast cell activation in vitro and in a model of 
allergic airway disease in vivo. Treatment with Kp and QE in vitro inhibited 
degranulation and cytokine production of bone marrow-derived mast cells following 
IgE/FcɛRI crosslinking, whereas treatment with QI had no effect. Similarly, in 
vivo treatment with Kp and QE decreased development of airway 
hyperresponsiveness, airway inflammation, goblet cell metaplasia and production of 
IL-5, IL-13 and TNF. In contrast, treatment with QI had no effect on these 
parameters. These findings demonstrate that treatment with Kp or QE is effective in 
treatment of allergic airway disease, providing new insights to the 
immunomodulatory functions of this plant. Haldina Cordifolia     Pinnata inhibits mast 
cell activation and prevents allergic airway disease. 
 Shazid et al., (2012) [30] reported on the elucidated structure under the title 
Chemical and biological studies of Haldina Cordifolia Pinnata (Lam.) growing in 
Bangladesh.In this study they  isolated compounds from K. Pinnata and elucidated 
their structures and to explore preliminary antioxidant, antimicrobial, cytotoxic and 
thombolytic activities of extractives of  the plant. The methanol extract of whole plant 
of K. Pinnata has been subjected to different chromatographic separation and 
purification processes to isolate the secondary metabolites. The structures of the 
isolated compounds have been elucidated by extensive NMR studies. 
 Patil et al., (2013)[31] reported under Antidiabetic activity of Haldina Cordifolia     
Pinnata in streptozotocin-induced diabetic rats by glucose independent insulin 
secretagogue action about the anti diabetic action of K.Pinnata in wich it was 
reported that it reduces fasting blood glucose level  
 Gad et al., (2006)[33] studied on Biochemical study of the anti-diabetic action 
of the Egyptian plants fenugreek and balanites.It proceeded by evaluating the 
effects of 21 days oral administration of Fenugreek seed and Balanites fruit 
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extracts (1.5 g/kg bw) on the liver and kidney glycogen content and on some 
key liver enzymes of carbohydrate metabolism in STZ-diabetic rats were 
studied. In addition, the effects of these two plant extracts on the intestinal 
alpha-amylase activity in vitro and starch digestion and absorption in vivo 
were also examined. . 
 Patil et al., (2013) [41] reported on hypoglycemic activity on Haldina Cordifolia     
Pinnata Lam. (Crassulaceae) under the title Antidiabetic activity of Haldina Cordifolia     
Pinnata in streptozotocin-induced diabetic rats by glucose independent insulin 
secretagogue action.The probable mechanism for insulin secretagogue action was 
evaluated through studies using diazoxide and nifedipine. The bioactive component 
from DCM fraction was studied using HPTLC, GCMS and IR.  
 Dzhafarova et al., (2009) [28] reported on Antidiabetic action of extract of 
Juglans Regia LThe study is on the impact of Iuglans Regia L on the pathological 
processes in alloxan-indeced dibatic animals. The investigation showed that extract 
from wall nuts leaves decreases the blood sugar level, has a positive impact on lipid 
metabolism. Antioxidant properties of an extract from leaves of the walnut tree 
(Juglans regia) are reported. 
 Radhika et al., (2011)[36] Did a major evaluation on Antidiabetic and 
Hypolipidemic Activity of Punica Granatum Linn on Alloxan Induced Rats the study 
aimed to evaluate the antidiabetic and hypoglycemic activity of Punica granatum. 
Diabetes & hyperlipidemia was induced by the intra peritoneal injection of alloxan 
mono hydrate (120mg/kg) for 2 consecutive days. Diabetes was confirmed 2days 
after the last alloxan dose administration by determining the blood glucose 
concentration. Treatments were started after confirmation of diabetes in rats.During 
diabetes, the excess glucose present in the blood reacts with hemoglobin to form 
glycosylated hemoglobin. So the total hemoglobin level is lowered in alloxan induced 
diabetic rats. Alloxan induced diabeteshas been observed to cause a massive 
reduction of the beta cells of the islets of pancreas leading to hyperglycemia. Rats 
treated with alloxan (120mg/kg), for 2 consecutive days, showed an increase in the 
concentration of glucose, triglycerides, cholesterol, LDL cholesterol, VLDL 
cholesterol and a decrease in the level of HDL cholesterol and hemoglobin content. 
Administration of crude powder of Punica granatum husk reduced the concentration 
of glucose, triglycerides, cholesterol, LDL cholesterol, VLDL cholesterol and raised 
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the level of HDL cholesterol and hemoglobin content in the blood of both group-I 
normal and group III alloxan diabetic rats treated. 
 Saif-Ur-Rehman et al., (2011) [38] presented the  work on Antidiabetic Effect 
of Aloe vera Extract on Alloxan Induced Diabetic Rats.It was carried out to 
investigate the antidiabetic effect of Aloe vera extract in normal and alloxan induced 
diabetic rats.  
 Kuroda et al., (2005) [40]  studied on the turmeric (Curcuma Longa L. 
rhizomes) EtOH extract the Hypoglycemic effects of turmeric (Curcuma Longa L. 
rhizomes) on genetically diabetic KK-Ay mice it shows significant suppression and 
an increase in blood glucose level in type 2 diabetic KK-A(y) mice. 
 Mondal et al., (2008) [27] did a preliminary and antidiabetic screening on the 
title  Antidiabetic activity of Diospyros Malabarica Kostel bark: a preliminary 
investigation for possible mode of action The extract exerted significant 
antihyperglycemic effect in alloxan-induced hyperglycemia and resulted in increase 
in plasma protein content and decrease in alkaline phosphatase, cholesterol and 
triglyceride levels when compared with those in the diabetic control group. However 
there were no significant changes in body and kidney weights of the DM extract-
treated animals, compared to those of the untreated diabetic rats as a control.  
 Grover et al., (2002)[40] conducted a research of Medicinal plants of India with 
anti-diabetic potential on the plants mentioned in ancient literature or used 
traditionally for diabetes have shown anti-diabetic property. The present paper 
reviews 45 such plants and their products (active, natural principles and crude 
extracts) that have been mentioned/used in the Indian traditional system of medicine 
and have shown experimental or clinical anti-diabetic activity. 
 Rajnish Gupta et al., (2011)[46] reported on Antidiabetic efficacy of  Mangifera 
Indica seed kernels in rats. The study was conducted to examine the hypoglycemic 
potency of seed kernels of Mangiferaindica ethanol extract (MIEtE) in 
streptozotocindiabetic rats. Remarkable abnormalities were observed in serum and 
tissue parameters in hyperglycemic rats after streptozotocin administration 
 Sabjan Khaleel Basha and Vinoji Sugantha Kumari.(2012)[50] reported on 
In vitro antidiabetic activity of Psidium Guajava seeds extracts. In this they did the 
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evaluation of the glucose uptake of (antidiabetic activity) crude n-hexane, ethanol, 
ethanol and aqueous leaf extracts of P.guajava. Methods: P.guajava leaf extracts 
were subjected to inhibitory effect of glucose utilization using specific standard in 
vitro procedure. 
 Yoshino  et al., (2009)[42] reported on the title Anti-diabetic activity of a leaf 
extract prepared from Salacia Reticulata in mice The effects of a water extract 
prepared from the leaves of Salacia reticulata on the absorption of sugars in normal 
and type 1 diabetic mice were investigated.  
 Akhani et al., (2004)[22] reported on antidiabetic study of  Zingiber officinale 
Roscoe as Anti-diabetic activity of Zingiber Officinale in streptozotocin-induced type I 
diabetic rats The fresh and dried rhizome of Zingiber officinale Roscoe (commonly 
known as ginger) is widely used in traditional medicine.The study is on the effect of 
the juice of Z. officinale (4 mL kg(-1), p.o. daily) for 6 weeks on streptozotocin (STZ)-
induced type I diabetic rats with particular reference to the involvement of serotonin 
(5-hydroxytryptamine; 5-HT) receptors in glycaemic control. 
 Ramadan et al., (2013) [28] observed two parameters on the diabetic induced 
rat on title Hypoglycemic and hepatoprotective activity of Rosmarinus Officinalis 
extract in diabetic rats The present study examined the effect of water extract (200 
mg/kg body weight) of Rosmarinus officinalis L. in streptozotocin (STZ)-induced 
diabetic rats for 21 days. The hepatoprotective effects were investigated in the liver 
tissues sections. 
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CHAPTER-III 
3. AIM AND OBJECTIVE 
 
 The Diabetes Mellitus is worldwide problem due to the lifestyle changes lead 
to decreased physical activity, increased consumption of fat, sugar and calories, and 
higher stress levels, affecting insulin sensitivity and obesity. Based on the above 
causative factor to increased tenfold, from 1.2% to 12.1%, between 1971 and 2000 
entire world. It estimates is estimated that 61.3 millions people aged 20-79 years live 
with diabetes in India (2015). This number is expected to increase to 101.2 millions 
by 2030. There are many synthetic drugs used for the treatment of diabetes such as 
Glibenclamide-sulphonylureas in India and combination therapy because its more 
side effects reported. Several literatures indicated that the herbal drugs are less 
adverse effect when compared with synthetic drugs. Haldina Cordifolia one of most 
traditionally using hypoglycemic drug among tribes in india and its same species 
K.Pinnata was scientifically reported but Haldina Cordifolia   is not scientifically 
validated.  Based on the above mentioned reasons, one new research is required to 
develop one new drug with activity and less side effects, which will be work 
multifactorial antidiabetic mechanism. Allopathic medicines are very costly contrast 
to herbal medicines are very cheap. This cost effectiveness makes them all the more 
alluring. The work provides scientific validation for the use of leaf against diabetes by 
revealing the chemical compounds may be present in the plant. The prediction of 
biological activity of the chemical compounds present in the extract wills supports the 
invitro results after its phytochemical analysis. Herbal drugs were expelled milde side 
15 
 
effects reported in literatues. The present study is attempt to develop a novel plant 
based antidiabetic drug, which will be evaluated by using Invitro and Invivo methods 
 
 
 
 
 
 
 
CHAPTER-IV 
4. PLAN OF WORK 
 
1. Collection and authentification of the genuine plant material. 
2. Shade drying and granulation of the dried leaves. 
3. Sequential extraction of the plant material using petroleum ether, ethyl 
acetate and ethanol. 
4. Invitro antidiabetic study using α-amylase inhibition assay. 
5. Selection of active extract with higher activity. 
6. Phytochemical analysis of active extract. 
7. Acute toxicity study. 
8. Invivo antidiabetic study of active extract. 
I) Normal animal 
a) OGTT 
b) Hypoglycemic 
II) Streptazocin induced diabetes mellitus 
      a) Multiple dose study 
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CHAPTER-V 
 
5.PLANT PROFILE 
 
  
Fig No 2. Plant of Haldina Cordifolia-I 
17 
 
 
Figure No 3. Plant of Haldina Cordifolia-II 
 
Fig No. 4. Plant of Haldina Cordifolia-III 
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Fig No. 5. Plant of Haldina Cordifolia-IV 
 
 
Fig No. 6. Plant of Haldina Cordifolia-V 
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Fig No. 7. Plant of Haldina Cordifolia-VI 
 
 
Fig No. 8. Plant of Haldina Cordifolia-VII 
 
5.1 Haldina Cordifolia     
20 
 
Herbalism or "herbal medicines” have a long history to cure several kinds of human 
diseases from the various parts of the plants such as leaf, stem, bark, leaf, etc. [2] 
Plants have been the basis for medical treatments through much of human history, 
and such traditional medicine is still widely practiced today. Modern medicine 
recognizes herbalism as a form of alternative medicine, as the practice of herbalism 
is not strictly based on evidence gathered using the scientific method. Many of the 
pharmaceuticals currently available to physicians have a long history of use as 
herbal remedies, including opium, aspirin, digitalis, and quinine. The World Health 
Organization (WHO) estimates that 80 percent of the population of some Asian and 
African countries presently uses herbal medicines for some aspect of primary health 
care. The use of, and search for, drugs and dietary supplements derived from plants 
have accelerated in recent years. Pharmacologists, microbiologists, botanists, and 
natural-products chemists are combining the Earth for phytochemicals and leads that 
could be developed for treatment of various diseases. Among the 120 active 
compounds currently isolated from the higher plants and widely used in modern 
medicine today, 80 percent show a positive correlation between their modern 
therapeutic use and the traditional use of the plants from which they are derived. 
More than two thirds of the world's plant species at least 35,000 of which are 
estimated to have medicinal value come from the developing countries [1] . It was 
realized from the various reports that Haldina cardifolia, belongs to the family 
Rubiaceae, have displayed plethoras of potential biological activities such as 
anticancer, hepatoprotective, antiinflammatory, antifertility, antidiabetic, antiamoebic, 
antinociptive etc. from its various parts . Furthermore, this plant have also used in 
curing various ailments such as rheumatism, stomachache,headache, cold/cough, 
toothache, fever, pain and swelling, bacterial infection, urinary problems, 
conjunctivitis, miscarriage etc. Keeping the view of the above mentioned medicinal 
importance of this plant, we therefore became interested to investigate the 
antibacterial activity of this plant. To the best of our knowledge, the antibacterial 
activity from this plant has not been reported so far till now. In the present paper, we 
would like to explore the antibacterial activity of the methanolic extract this plant 
employing various kinds of strains. It was found that majority of these strains 
employed, have displayed potential antibacterial activity. Introduction to the plant 
Adina cordifolia Roxb. (Synonym: Haldina cordifolia) Family: Rubiaceae Vernacular 
names: English : Yellow teak 1 Sanskrit : Haridru Hindi : Haldu Telugu : 
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Pasupukadamba Kannada: Hethega, Arisina tega Morphology A hulking deciduous 
tree with the shoot often irregularly fluted and buttress at the bottom and normally 
reaching 6m girth and 15-35m in height. It is a blossoming plant in the family 
Rubiaceae. Bark to a degree dark grey, thick, bumpy or blackish and to a certain 
extent pale ashy or silvery white, wood yellow moderately rigid and even-grained. 
Leaves opposite 10-25cm width, orbicular, abruptly acuminate, pedestal cordate, 
glabrous above pubescent beneath, with 5-8 pairs of sideways nerves. Petiole 3.8-
10cm extended stout, juvenile. Stipules 1.3-1.8cm long oblong or obovate. Flowers is 
irrelevant individually but is very attractive when they blossom together in balls with a 
perimeter of 2 to 3cm. They are usually yellow in shade often tinged with a shade of 
pink. Fruits capsules split into two dehiscent cocci. Seeds many slender small tailed 
above. 
 
 
CHAPTER-VI 
 MATERIALS AND METHODS 
6.1.1 Plant collection and authentification 
The leafs of Haldina Cordifolia    were collected from Nilgiri hills Gudalur, 
Kerala and which was authenticated by Dr.Raghu.A.V Scientist-B,Extension & 
Training, Kerala Forest Research institute Peechi – 680 653, Thrissur.  
6.1.2 Preparation of  coarse powder and Extraction technique 
The leafs were shade dried at room temperature for 10 days. Then these 
were milled into powder by mechanical grinder. This powder was sequentially 
extracted to their increasing polarity with Petroleum ether, Ethyl acetate, Ethanol 
respectively. About 500gm of powdered leaf was uniformly packed into a thimble in a 
soxhlet apparatus and extracted with 1000ml Petroleum ether, Ethyl acetate and 
Ethanol, respectively. Constant heat was provided by Mantox heater for recycling of 
the solvent. The process of extraction continues for 1-2 hours for each solvent. The 
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excess solvent was evaporated and the dried extracts were kept in refrigerator at 
4ºC for their future use in phytochemical analysis and pharmacological screenings. 
6.1.3 Invitro antidiabetic activity  of Haldina Cordifolia    leaf extracts 
6.2 Alpha-amylase inhibition assay 
6.2.1 Chemicals or reagents 
Potato starch, trichloroacetic acid, Folin-Ciocalteau reagents were purchased 
from SD Fine Pvt. Ltd., Mumbai, 3,5-dinitrosalicylic acid, Tris buffer, linoleic acid, 
ammonium molybdate, were purchased from Hi-Media Pvt. Ltd., Mumbai, α-amylase, 
α-glucosidase enzymes, xanthine oxidase, quercetin, hypoxanthine, pyrocatechol 
were purchased from SRL Pvt. Ltd., Mumbai. Glucose assay kit from Agappe 
diagnostic Pvt. Ltd., Kerala, Acarbose was obtained from Bicon Pvt. Ltd., Chennai, 
ferrozine, (2'2-azobis (2-amidino propane) dihydrochloride), butylated hydroxy 
toluene from Loba Cheme. All other chemicals used in the study were obtained 
commercially and were of analytical grade. 
 
  
6.2.2 Instrument used 
UV-visible Spectrometer (Systronic double beam- UV-2201). 
6.2.3 Preparation of extract 
Leaf extraction used in invitro and invivo studies were prepared by using 
suitable solvents (Carboxy methyl cellulose). 
6.2.4 Experimental procedure for α-amylase inhibition assay 
A total of 500 µl of test samples and standard drug (100-1000µg/ml)  
were added  to  500  µl  of  0.20  mM  phosphate  buffer  (pH  6.9)  containing  
α-amylase (0.5mg/ml) solution and were incubated at 25°C for 10 min. After 
these, 500 µl of a 1% starch solution in 0.02 M sodium phosphate buffer (pH 
6.9) was added to each tube. The reaction mixtures were then incubated at 
25°C for 10 min. The reaction was stopped with 1.0 ml of 3, 5 dinitro salicylic 
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acid colour reagent. The test tubes were then incubated in a boiling water bath 
for 5 min, cooled to room temperature. The reaction mixture was then diluted 
after adding 10 ml distilled water and absorbance was measured  at  540  
nm.  Control  represent  100%  enzyme  activity  and  were 
conducted in similar way by replacing extract with vehicle. 
Calculation of 50% inhibitory concentration (IC50) 
             The concentration of the plant extracts required to scavenge 
50% of the radicals (IC50) was calculated by using the percentage 
scavenging activities at five different concentrations of the extract. 
Percentage inhibition (I %) was calculated by 
 
 
 
 
 
 
 
 
(Ac-As) 
       I %  =       ---------------  x 100 
Ac 
where, 
Ac      =  Absorbance of the 
control 
As      =  Absorbance of the 
sample. 
 
6.3 Thin layer chromatographic profiling 
6.3.1 Practical requirements 
Stationary phases 
Glass plates 
Mobile phase 
Preparation and activation of TLC plates 
Application of sample  
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Development tank  
Development technique 
Detecting or visualizing agents 
6.3.1.1 Glass plates 
  Specific dimensions like 20 cm*20cm (full plate), 20cm*10cm (half plate), 
20cm*5cm (quarter plate) can be used. It should be good quality and can withstand 
temperature used for drying. 
6.3.1.2 Preparation and activation of TLC plates   
 Mixture of stationary phase and water forms slurry. TLC plates prepared by 
pouring, dipping , spraying or spreading. In pouring technique, slurry prepared and 
poured on the glass plate. Slurry spread uniformly on glass plate. Plates are dried in 
oven. In dipping technique two plates dipped in slurry, separated and dried. 
Disadvantage is that large quantity slurry required. 
 
 
6.3.1.3 Spreading technique   
 In this technique TLC spreader is used. The glass plates are stacked on base 
plate. Slurry poured in the reservoir of TLC spreader. Thickness adjusted using knob 
in the spreader. 0.25 mm is normally used thickness for analytical purposes. 
Spreader rolled on the plates and air drying the plates. Plates are activated by 
keeping at 100 degree Celsius to 120 degree Celsius for one hour. Activated plates 
can be stored in thermostatically controlled oven for further use.  
6.3.1.4 Application of sample 
  The concentration of sample of standard should be minimum for good spots. 
2- 5ug of 1% solution of standard or sample spotted using capillary tubes. Spots 
should be 2 cm above the base of plate and spotting area should not be immersed in 
mobile phase. At least 4 spots can be spotted on quarter plate.  
6.3.1.5 Development tank  
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The developing tanks require more solvent for developing tank –having hump 
in the middle and require less solvent. It should be lined inside with filter paper 
moistened with mobile phase 
6.3.1.6 Mobile phase   
The solvent or mobile phase depends on various factors. 
Nature of substance 
Nature of stationary phase 
Mode of chromatography 
Separation to be achieved. Analytical or preparative 
6.3.2 Procedure 
 Commercial sheet pre coated with silica gel are available. Select a solvent by 
testing out the samples in various solvents. Dissolve a small quantity of ethanolic 
extract of Haldina Cordifolia    leaf of the unknown in different flask containing 
solvents of different polarity. Place the TLC plates, the spotted side down in to the 
chamber so that the lower the pencil line about the solvents. Remove the plate from 
the development chamber and allowed to dry. Plate is placed under UV light, dark 
spots are observed. 
6.3.3 Quantitative analysis 
 
                  Rf =      Distance moved by solute                               
                              Distance moved by solvent 
                 
                  Rf = retardation factor  
 
6.4 Preliminary phytochemical screening of ethanolic leaf extract of Haldina 
Cordifolia    
  The ethanolic leaf extract of Haldina Cordifolia    was used for testing 
preliminary phytochemical screening in order to detect major chemical groups. 
6.4.1 Test for carbohydrates 
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 Molisch’s test: Dissolved small quantity of 300mg alcoholic and dried leaf 
extract powder of Pimenta dioica separately in 4ml distilled water and filtered. The 
filtrate was subjected to Molisch’s test.  
 Fehling’s test: Dissolve a small portion of extract in water and treat with 
Fehling’s solution. 
 Phenols test: The extract was spotted on a filter paper. A drop of 
phosphomolybdic acid reagent was added to the spot and was exposed to ammonia 
vapours. 
6.4.2 Test for flavanoids  
 Shinoda test: To 2 to 3ml of extract, a piece of magnesium ribbon and 1ml of 
concentrated HCl was added . 
 .Lead acetate test: To 5ml of extract 1ml of lead acetate solution was added.  
6.4.3Test for tannins 
 Braemer’s test: To a 2 to 3ml of extract, 10% alcoholic ferric chloride solution 
was added. 
 
 
 
6.4.4 Test for steroid/terpenoid 
 Liebermann-Burchardt test: To 1ml of extract, 1ml of chloroform, 2 to3ml of 
acetic anhydride and 1 to 2 drops of concentrated Sulphuric acid are added. 
6.4.5  Test for alkaloids 
 Draggendorf’s test: A drop of extract was spotted on a small piece of 
precoated TLC plate and the plate was sprayed with modified Draggendorf’s 
reagent.  
 Hager’s test: The extract was treated with few ml of Hager’s reagen. 
 Wagner’s test: The extract was treated with few ml of Wagner’s reagent. 
6.4.6 Tests for Glycosides 
 Legal’s test: Dissolved the extract [0.1g] in pyridine [2ml], added sodium 
nitroprusside solution [2ml] and made alkaline with Sodium hydroxide solution. 
6.4.7 Test for Saponins 
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 Foam test: 1ml of extract was dilute with 20ml of distilled water and shaken 
with a graduated cylinder for 15 minutes. 
6.4.8 Test for Anthraquinones 
 Borntrager’s test: About 50 mg of powdered extract was heated with 10% 
ferric chloride solution and 1ml of concentrated HCl. The extract was cooled, filtered 
and the filtrate was shaken with diethyl ether. The ether extract was further extracted 
with strong ammonia. 
6.4.9 Test for Amino acids 
 Ninhydrin test: Dissolved a small quantity of the extract in few ml of water and 
added 1ml of ninhydrin reagent. 
6.4.10 Test for fixed oils and fats 
  Press small quantity of the petroleum ether extract between two filter paper. 
Note: the results for the above experiments can be noted as follows. 
 If the response to the test is high it can be noted as +++which indicates that 
the particular group is present as the major class. 
 If the response is average then note it as ++ indicates the presence in 
moderate quantity. 
 If the response is very small then note it as + indicating the presence of only 
in traces. 
 If no response is then negative. 
 
6.5 Acute toxicity study 
 In a research study when a drug is administered to a biological system there 
will be some interactions may happen .In most case these are desired and 
usefull,but many effects are not advantageous. Acute, subacute and chronic toxicity 
studies are performed by the manufacturers in the investigation of a new drug.Acute 
toxicity is involved in estimation of LD50(It is the lethal dose (cuasing death)to 50% of 
tested group animals)54. 
6.5.1 LD50 (median lethal oral dose) 
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LD 50 (median lethal oral dose) is a statistically derived oral dose of a 
substance that can be expected to cause death in percent of animals when 
administered by the oral route.The LD50 value is expressed in terms of weight of test 
substance per unit weight of animal(mg/kg) 
  In this study acute toxicity study was carried out in wistar albino rats.The 
procedure was followed by using OECD 423(Acute toxic class method).The rats are 
fasted overnight,prior to dosing.The three dose levels are administered by the help of 
oral feeding needle over the prior of 24 hours.After the drugs has been 
administered,food may be with held for a further 3-4 hours in rats.The purpose of 
sighting study is to allow selection of the appropriate starting dose for main 
study.The test substabce is administered to a single animal in a sequential manner 
following from the fixed dose levels of 5,50,300 and 2000mg/kg. The interval 
between dosing of each level is determined by the mortality/onset,duration and 
severisty of toxic signs over the period of 24 hours,special attention given during the 
first 4 hours. Four hours after the drug administration,provide the food and water for 
14 days and daily observed some parameters such as food intake,water 
intake,mortality,onset,Duration and severity of toxic signs.The animal weight is 
recorded on weekly once.On the day fourteen all the animals are sacrificed,to isolate 
the organs and observe the histopathological changes.Based on the mortality result 
of sighting is decided and carried out with five animals per dose level (5 or 50 or 300 
or 2000mg/kg).Based on the mortality result on 14th day of observation,the doses for 
invivo study are selected.  
6.6  Invivo  antidiabetic  activity    of  Haldina Cordifolia     leaf extract in 
streptozotocin induced diabetic wistar albino rats. 
Wistar albino rats (150- 200 grams) of both sexes were procured from 
Karpagam college of pharmacy laboratory Prior to the experiment the rats 
were housed in a clean polypropylene cages (6 rats/ cages) for a period of 7 
days under standard temperature (25 - 30o  c) , relative humidity (45 – 55%), 
dark / light cycle (12 /12 hrs). The studies were performed with the approval 
of Organisational Animal Ethics Committee (OAEC) (KU/IAEC/M.Pharm/173).  
The animals were put in overnight fasting were deprived of food for 16 hrs but 
allowed free access of water. 
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6.7 Chemicals 
 Streptozotocin from   Loba Chemie. Standard Glibenclamide (Daonil) from 
Aventis Pharma. Ethanol (Analytical grade) and 5% Dextrose solution Glucose 
Estimation Kit from  Gluco Dr Super sensor 
6.8 Hypoglycemic Test 
Groupings were done as follows: Group I served as control – Carboxy Methyl 
Cellulose (CMC) 0.5% (0.3ml\100g rat), Group II served as Positive control – 
Glibenclamide (2mg /kg), Group III served as  aqueous ethanolic extract of Haldina 
Cordifolia   – (200mg/kg), Group IV served as  aqueous ethanolic extract of Haldina 
Cordifolia   – (400mg/kg). Blood samples were collected by the tail nipping method 
and glucose level checked by glucometer.  After  drug Administration blood samples 
have been collected  different time intervals at 30, 60 and 120. 
6.9 Oral Glucose Tolerance Test 
Groupings were done as follows: Group I served as control – Carboxy Methyl 
Cellulose (CMC) 0.5% (0.3ml\100g rat), Group II served as Positive control – 
Glibenclamide (2 mg /kg), Group III served as  aqueous ethanolic extract of Haldina 
Cordifolia   – (200mg/kg), Group IV served as  aqueous ethanolic extract of Haldina 
Cordifolia    – (400mg/kg). All the groups of animals were fasted for 24h and blood 
samples were collected before drug or solvent treatment. The drug, extract and 
solvent, have been adminisratered to different groups and  30mins later all the 
groups of rats were treated  with glucose orally at dose 10gm/kg body weight by 
using oral feeding needle.  Blood samples were collected by the tail nipping method 
and glucose level checked by glucometer.  After drug Administration blood samples 
have been collected different time intervals at 30, 60 and 120. 
 
6.10 Induction of diabetes to animals 
A single dose (100 mg/kg b.w., i.p.)  of streptozotocin monohydrate  
dissolved in sodium citrate buffer was used for the induction of diabetes in 
rats after overnight fasting. After 1 hr of streptozotocin monohydrate 
administration, the animals were given feed and libitum  and  5%  dextrose  
solution  was  also  given  in  feeding  bottle  for  a  day  to overcome early 
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hypoglycaemic  phase. The animals were stabilized for a week and animals 
showing blood glucose level more than 200 mg/dl were selected for the study. 
6.11 Experimental design 
Five  groups  of  rats  six  in  each  groups  received  the  following  
treatment schedule for 14 days. 
GROUP I        -          Normal control (normal saline 10 ml /kg, P.O) 
        GROUP II      -          Streptozotocin treated control (100 mg/kg, I.P)  
        GROUP III     -          Streptozotocin (100 mg/kg, I.P) + 
  Standard drug Glibenclamide (2 mg/kg, P.O). 
GROUP IV      -       Streptozotocin (100 mg/kg, i.p.) + EEEVL.(200 mg/kg, 
P.O)  
GROUP V       -      Streptozotocin (100 mg/kg, i.p.)+ EEEVL. (400 mg/kg, 
P.O) 
 Plant leaf extract, standard drug and normal saline were administered with 
the help of oral feeding needle. Group I serve as normal control which received 
normal saline for 14 days. Group II to Group V were diabetic control rats. 
Group IV and Group  V (which  previously  received  streptozotocin100mg/kg)  
were given  fixed  doses  of ethanol leaf extract (200 mg/kg, P.O, 400 mg/kg, 
P.O) of Haldina Cordifolia    and group III received standard drug Glibenclamide (2 
mg/kg,P.O) for 14 consecutive days.(EEKAKA-Ethanolic extract of Haldina 
Cordifolia   ). 
6.12 Collection of blood samples 
 Fasting blood samples were drawn from retro orbital puncture of rats at 
weekly intervals till the end of the study 1, 7, and 14 days. 
6.13 Estimation of biochemical parameters Serum blood glucose 
 On  1,  7,  and  14  days  fasting  blood  samples  were  collected and 
analyzed the blood glucose. 
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6.14 Blood glucose level 
 The blood glucose level test measures the amount of glucose in the blood 
sample obtained from the animals. The test is usually performed to check for 
elevated blood glucose levels which can be an indication of diabetes or insulin 
inhibition. 
6.15 Statistical analysis 
 Statistical analysis was done by using GRAPHPAD PRISM 5.0.All the 
values of Biochemical parameters and body weight were expressed as Mean ± 
Standard Error Mean (SEM). The values were analyzed for statistical significance 
using one- way analysis of variance (ANOVA), comparison was done by using 
Dunnett’s t test. P values < 0.05 were considered as significant, P values < 0.01 
were considered as very significant, P values < 0.001 were considered as highly 
significant and ns were considered as not significant.  
 
 
 
CHAPTER-VII 
7.RESULTS AND DISCUSSION 
7.1 Appearance and percentage yield of EEHC (Ethanolic Extract of Haldina 
Cordifolia  Leaf ) 
 EEHC was a semisolid brownish colour extract and the percentage yield was found 
to be 14.35% 
7.2 invitro antidiabetic study  
%Inhibition of Petrolium ether extract of Haldina Cordifolia    leaf  = 91 µg/ml 
%Inhibition of Ethyl acetate extract of Haldina Cordifolia       leaf   =  80 µg/ml    
%Inhibition of Ethanolic extract of Haldina Cordifolia           leaf   =  75 µg/ml          
%Inhibition of Acarbose (Positive control)                                        =  61 µg/ml      
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 Minimum % Inhibition   was found in Ethanolic extract of Haldina Cordifolia    
leaf wich resemblance to %Inhibition of positive control, So Ethanolic extract of 
Haldina Cordifolia    contain active constituents of antidiabetic. 
    
             Table No:2, α-Amylase Inhibition of Petroleum Ether extract of   Haldina 
Cordifolia    leaf 
Concentration(µg/ml) Percentage Inhibition (%) 
0 0 
25 29 
50 33 
75 42 
100 53 
125 56 
 
 
 
 
 
Fig No :9 
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    Table No:3, α-Amylase Inhibition of  Ethyl acetate Extract of Haldina 
Cordifolia    leaf 
Concentration(µg/ml) Percentage Inhibition(%) 
0 0 
25 34 
50 41 
75 48 
100 56 
125 60 
 
 
 
 
 
 
Fig No:10 
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        Table No:4, α-Amylase Inhibition of  Ethanolic Extract of Haldina 
Cordifolia   leaf 
Concentration(µg/ml) Percentage Inhibition(%) 
0 0 
25 30 
50 36 
75 50 
100 56 
125 61 
 
 
 
 
 
 
 
Fig No:11 
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                Table No:5, α-Amylase Inhibition  of Acarbose  (Positive control) 
Concentration(µg/ml) Percentage Inhibition(%) 
0 0 
25 25 
50 45 
75 53 
100 56 
125 65 
 
 
 
 
 
 
 
 
 
 
      Fig No:12 
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7.4 TLC study  
Rf Value range high-Polar substances present. 
Rf value range low-Low polar substance present. 
Solubility of compounds depend upon the polarity of solvents. 
Obtained Rf values were confirmed by standard Rf values. 
 Rf values obtained for my extract ranges from 0.56 to 0.88,So my extract may 
contain compounds like Flavanoids,Glycosides and Alkaloids. 
 
           Table No: 6, Results of ethanolic extract of Haldina Cordifolia    
Si 
No. 
Solvents Concentration Rf  value 
1. 
 
Toluene + Ethyl acetate 7:3 0.62 
2. Toluene + Ethyl acetate + Glacial 
acetic acid 
5:5:1 0.76 
3. Petrolium ether+Chloroform 7:3 0.56 
4. Ethyl acetate + Methanol 
 
1:1 0.88 
C
o
n
ce
n
tr
a
ti
o
n
 m
cg
/m
l 
% Inhibition 
α-Amylase Inhibition  of Acarbose 
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5. Hexane+Dichloro methane 1:1 0.67 
6. Ethyl acetate + Methanol 3:1 0.59 
7. Dichloro methane +Hexane 3:1 0.72 
 
 
7.5 Phytochemical studies 
 
The phytochemical studies results revealed that the Molisch’s test no 
characteristic observation indicated the absence of carbohydrates, by 
phosphomolybdic acid test Blue coloration of the spot indicated the presence of 
phenols. Shinoda test and Lead acetate test gave pink or red coloration of the 
solution indicated the presence of flavonoids Flocculent white precipitate also 
indicated the same. There is no dark blue or greenish grey coloration of the solution 
indicated the absence of of tannins in the drug. No characteristic observation for 
steroids and dark pink or red coloration of the solution indicated the presence of 
terpenoids. Orange coloration of the spot indicated the presence of alkaloids. Yellow 
or reddish brown precipitation precipitation indicated the presence of alkaloids. Pink 
to red colour solution indicates the presence of glycosides. No layer of foam 
formation indicates the absence of Saponins.  it as + indicating the presence of  
traces. If no response is then negative.   
 
 
 
 
 
 
 
 
 
Table No :7 , Results of ethanolic extract of Haldina Cordifolia    
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Class of  compounds 
 
Tests performed 
 
Results  
 
 
Carbohydrates 
 
Molisch’s test 
Fehling’s test 
 
 
- 
 
Phenols 
 
Phosphomolybdic acid 
test 
 
+ 
 
Flavonoids 
 
Shinoda test 
Lead acetate test 
 
+ 
+ 
 
Tannins 
 
Braemer’s test 
 
_ 
 
Alkaloids 
Wagner’s 
Mayer’s 
Draggendrof’s test 
+ 
+ 
+ 
 
Glycosides 
Legal’s test 
Brontranger’s test 
+ 
 
+ 
 
Saponins 
 
Foam test 
 
+ 
 
Sterols 
 
Salkowski’s test 
 
_ 
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Amino acids 
 
Ninhydrin test 
 
_ 
 
Terpenoids 
 
Lieberman Burchardt 
test 
 
+ 
 
+ In traces 
-Absence 
 
7.6 Hypoglycemic Test 
 
   The glucose levels were analyzed by using glucometer and each value is the 
mean ± standard error (n= each group consist of 6 animals)(p<0.05)*, (p<0.001)**& 
(p<0.0001)*** as compared to control & positive control group evaluated by one  
way, ANOVA followed by Dunnet ‘t’ test.  
The hypoglycemic test results have shown Table No:8, which indicated  
aqueous ethanolic extract of Haldina Cordifolia    treated animals 200 & 400,  
significantly decreased in blood glucose level (0.84± 1093↓ & 18.83±3.879↓) 
(P<0.05)*, (P<0.001)**&  (P<0.0001)*** when compared to control and positive 
control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table No-8, Hypoglycemic Test 
TREATMENT 
DOSE BLOOD GLUCOSE LEVEL (mg/dl) 
0 min 0.5hr 1 hr 
40 
 
 
 
 Fig No:13 
30MINS
co
nt
ro
l
po
si
tiv
e 
co
nt
ro
l
E
xt
ra
ct
 2
00
m
g/
kg
E
xt
ra
ct
 4
00
m
g/
kg
0
20
40
60
80
GROUPS
B
L
O
O
D
 G
L
U
C
O
S
E
 L
E
V
E
L
 (
m
g
/d
l)
 
Fig No:14 
mg/kg 
CONTROL 
CARBOXYME
THYL 
CELLULOSE(
CMC) 
0.5 %  68.00±2.429 68.17±2.587 71.83±2.372 
POSITIVE 
CONTROL 
Glibenclamide 
2 69.00±0.6325 52.83±4.037** 32.83±1.515*** 
AQUEOUS 
ETHANOLIC 
EXTRACT OF 
HALDINA 
CORDIFOLIA    
200  68.80±2.245 60.17±3.497* 59.33±3.584* 
AQUEOUS 
ETHANOLIC 
EXTRACT OF 
HALDINA 
CORDIFOLIA    
400 68.00±2.429 53.00±2.309** 34.17±1.138*** 
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7.7 Invivo antidiabetic study 
The experimental results have indicated on Table No:9. The negative control 
group glucose levels were significantly increased when compared to each other 
groups. All the groups of animals were affected in diabetes, which indicated blood 
glucose levels were slight changes in the blood glucose level  ( 4.13±1.207↓& 
1.±0.93↑) for normal control group at 7th and 14th days . On day 7th glucose levels 
were significantly decreased glibenclamide 2mg/kg treated group (120.2±1.414↓& 
23±1↓) (P<0.05)*, (P<0.001)**&  (P<0.0001)*** when compared with control group at 
7th and 14th days. The ethanolic leaf extract of Haldina Cordifolia    treated groups 
200 & 400 mg/kg were dose dependent manner decreased (P<0.001)**&  
(P<0.0001)*** (10±0.362↓& 90±1.67↓) when compared  with control group but 
positive control have more anti diabetic activity  at 7th day.  The aqueous ethanolic 
leaf extract of Haldina Cordifolia at the dose level 400mg/kg have equipotent activity 
(90±1.67 ↓&120.2 ±1.414↓ when compared with positive control at 7th day. The 
ethanolic leaf extract of Haldina Cordifolia    200 & 400 mg/kg have been expressed 
dose dependent anti diabetic action  (P<0.001) **& (P<0.0001) *** when compared 
to control and positive control. On day 14th, ethanolic leaf extract of Haldina 
Cordifolia treated animals 200 & 400 mg/kg significantly decreased and maintain the 
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blood glucose level (5.1±0.07↓ & 11±1.08↓), (P<0.001) **& (P<0.0001) *** when 
compared to control and positive control.  
 
Table No: 9, Results of the effects of ethanolic extract on blood Glucose levels 
 
SL. 
No. 
 
 
TREATMENT 
 
Blood glucose level (mg/dl) day 
 Day    1         Day 7 Day 14 
1 Normal control 
10 ml/kg P.O 
79.83±2.833 75.7±4.014 76.7± 4.944 
2 Negative control 
100 mg/kg I.P 
265.2±3.85 270.1±2.9 275.2±2.5 
3 Possitive control 
(Glibenclamide 2mg/kg) 
P.O 
255.83±2.386 135.63±3.8*** 112±2.8*** 
4 EEHC 200 mg/kg P.O  260±3.5
 
250.3±3.138** 245.2±3.250** 
5 EEHC 400 mg/kg P.O 263±4.55 173.1±2.88*** 162.1±1.8*** 
EEHC-Ethanoloc extract of Haldina Cordifolia    seed 
(The values were expressed as Mean ± S.E.M. (n=6 animals in each group). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.8 Oral Glucose Tolerance Test 
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The glucose level were analysed by using glucometer and all values are expressed 
as Mean±SEM (n=6), Group 2 was compared with group 1, Groups —3,4 were 
compared with group 2; *p<0.05, **p<0.01,p<0.001*** evaluated by one way, 
ANOVA followed by Dunnet ‘t’ test. 
Oral Glucose Tolerance Test (OGTT) results have been expressed on Table No: II. 
Half hour after the glucose treatment, all the groups of animal blood glucose levels 
were significantly increased (74.5±3.863↑, 35.2±6.6905↑, 59.5±3.764↑ & 
65.58±3.762↑). The blood glucose levels were significantly decreased for ,  aqueous 
ethanolic extract of Haldina Cordifolia    200 & 400 mg/kg (59.5±3.764↓& 
65.58±3.762↓ ) ↓), (P<0.001) **& (P<0.0001) ** when compared to control and 
positive control at 1hour and each and every ½ hour blood glucose levels(200 mg/kg 
: 8.8±3.26,10±0, 6.66±1.164 & 3±0.696, 400 
mg/kg:17.9±1.422,9.97±0,14.7±1.093&5±0.696) (P<0.05)*, (P<0.001)**&  
(P<0.0001)***  were changes in the dose dependent manner extract treated group of 
animals compared to control and positive control but 400mg/kg produce the 
equipotent activity. 
 
 
 
 
 
 
 
44 
 
Table No-10, Oral Glucose Tolerance Test 
 
TREATME
NT 
DOSE 
mg/kg 
BLOOD GLUCOSE LEVEL (mg/dl) 
0 min 0.5hr 1 hr 1.5hr 2 hr 2.5hr 3hr 
CONTROL 
CARBOXY
METHYL 
CELLULO
SE(CMC) 
0.5 %  68.00±2.42
9 
142.5±6.292 187.5±9.465 172.5±12.25 157.5±12.38 153.5±12.83 130.2±13.31 
POSITIVE 
CONTROL 
Glibenclam
ide 
2 69.00±0.63
25 
104.2±7.323** 110.5±6.980*** 93.67±1.308*** 83.67±1.308*** 77.17±4.070*** 74.33±2.940*** 
AQUEOUS 
ETHANOLI
C 
EXTRACT 
OF 
HALDINA 
CORDIFO
LIA    
200  68.80±2.24
5 
128.3±6.009 147.3±2.404* 138.5±5.667* 128.5±5.667* 113.8±6.760** 108.8±6.107** 
AQUEOUS 
METHANO
LIC 
EXTRACT 
OF 
HALDINA 
CORDIFO
LIA    
400 68.00±2.42
9 
115.0±6.191** 121.2±6.188** 103.3±4.766***
a 
93.33±4.766*** 
a 
86.67±3.602***a 83.67±2.906***
a 
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CHAPTER-VIII 
8.SUMMARY AND CONCLUSION 
Invitro study is on the principle of Inhibition of α-amylase, enzyme that 
plays a role in digestion of starch and glycogen are considered  a  strategy  
for  the  treatment  of  disorders  in  carbohydrate uptake,  such  as diabetes.  
Pancreatic α-amylase   is a key enzyme in the digestive system and 
catalyses the initial step in hydrolysis of starch to a mixture of smaller. 
Sequential extraction was done according to increasing polarity order 
(Petrolium ether,Ethyl acetate and Ethanol). Each extracts were tested for α-
amylase inhibition to get the extraction with minimum IC50 value.  As per the 
above mechanism all the extract have concentration dependent affinity 
towards the inhibition of α-amylase. Finally ethanolic extract was observed as 
more active extract. LC-MS is a hyphenated technique, combining the 
separation power of HPLC, with the detection power of mass spectrometry. 
Even with a very sophisticated MS instrument, HPLC is still useful to 
remove the interferences from the sample that would impact the ionization. 
Closely related to LC-MS are some other techniques, like flow injection/MS, 
CE or CEC/MS, capillary LC or Nano LC-MS In all cases, there is the need 
for an interface that will eliminate the solvent and generate gas phase ions, 
then transferred to the optics of the mass spectrometer. Most instruments 
now atmospheric pressure ionization (API) technique where solvent 
elimination and ionization steps are combined in the source and take place 
at atmospheric pressure. When electron impact ionization (EI) is the choice, 
the solvent elimination and ionization steps are separate. Present study I 
have been used LC-MS for isolate and characterize the antidiabetic active 
compounds from extract.  LC-MS for most active extract was taken and 
bioinformatics was collected by PASS. PASS is the computer generated 
program which provides the simultaneous prediction of several hundreds of 
biological activity types for any drug-like compounds. In this bio informatics 
software prediction is based on the analysis of structure-activity relationships 
of (SAR) the training set including more than 30000 known biologically active 
compounds .The most active antidiabetic constituent in the ethanolic extract 
of Haldina Cordifolia    was confirmed as Quercetin and other antidiabetic 
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active constituent was confirmed as Kaempferol. In  this  present  study  
Acute  toxicity  study  was    carried  out  in  rats.  The procedure was 
followed by using OECD 423 (Acute Toxic Class Method). The acute toxic 
class method is a step wise procedure with three animals of a single sex per 
step. Average  two to three steps  may  be necessary.  The method used 
to defined doses (2000, 1000, 500, 50, 5 mg/kg body weight, Up-and-
Down Procedure). The starting dose level of EEKAGA was 2000 mg/kg 
body weight p.o as most of the crude extracts posses LD50 value more than 
2000 mg/kg p.o and also found to be the maximum safe dose. Observe for 
signs for toxicity and were noted for 14 days. The onset of toxicity and signs 
of toxicity also noted. Hence, 1/10th (200mg/kg) and 1/5th (400mg/kg) of 
this dose were selected for further study.The principle involved in the alloxan 
induced diabetes mellitus in rats, Alloxan,  a beta cytotoxic, diabetes 
induced chemical but wide variety of animal  species  by damaging  the 
insulin  secreting  cells  of the pancreas.  Literature sources indicate that the  
alloxan induced rats  are  hyperglycaemic.  The treatment of lower doses of 
alloxan  (100mg/kg  b.w.)  produced  partial  destruction  of pancreatic  β-
cells  even though the animals become permanently diabetic. Thus these 
animals have surviving β-cells and regeneration is possible. It is well 
known that the sulfonylurea’s act by directly stimulating the β-cells of the 
islets of Langerhans to release more insulin and these compounds are active 
in mild alloxan induced diabetes. Invivo anti diabetic screening was 
performed for the confirmation of above mechanism of action was 
undergone  the ethanolic extract of Haldina Cordifolia    in biological system 
(Wich was already resulted for  α-amylase inhibitory activity by Invitro and 
constituents analysis by LCMS methods). At the end of the the ethanolic 
extract of Haldina Cordifolia   .(200  mg/kg  p.o,  400  mg/kg  p.o.)    showed 
statistically signif icant  decrease  in  blood  glucose levels. So the 
ethanolic extract of Haldina Cordifolia    showed antidiabetic activity. This 
work will be useful for further diabetes mellitus and it’s related diseases 
research worker to develop new entity for the treatment of diabetes mellitus. 
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            Extraction of leaf was done by sequential extraction method 
The leaves of Haldina cordifoliausing the solvent with increasing polarity order 
( petroleum ether,ethyl acetate and ethanol) and the active extract was tested 
by invitro antidiabetic screening method.The invitro antidiabetic study have 
been performed based on the α-amylase inhibition assay.Each extracts were 
tested for α-amylase inhibition and the extract with minimum IC50 have been 
undergone phyto chemical screening. The preliminary phytochemical tests 
was performed to identify the active phytochemicals present in the ethanolic 
extract ofHaldina cordifoliaand showed the presence of Phenols, Flavanoids, 
Alkaloids, Glycosides, Saponins and Terpenoids. LCMS analysis and PASS 
(bioinformatic software) was performed four compounds were found out 
Kaempferol,Rhamnetin,Rhamnoxanthin,Quercetin and luteolin. The 
antidiabetic constituents were found to be Quercetin(more active) and 
Kaempferol(less active). Finally the invivo antidiabetic activity of Ethanolic 
extract of Haldina cordifolialeaf was tested by using alloxan induced diabetic 
rat. Acute toxicity study was carried out in rats.The procedure was followed 
by OECD 423(Acute toxicity class method).1/10th  (200mg/kg)and 1/5th 
(400mg/kg)of the maximum safe dose (2000mg/kg)were selected for further 
study. Fasting blood sample were drawn from retino orbital puncture of rats 
at weekly intervals till the end of the study 1,7 and 14 days.On these days 
fasting blood glucose were collected and and analysed for glucose.At the end 
of the study (14th day)the ethanolic extract ofHaldina cordifolialeaf (200mg/kg 
p.o and 400 mg/kg p.o) treated diabetic groups showed statistically 
significant decrease in blood glucose similar to the standard drug 
glibenclamide(2mg/kg), which indicated block the alfa amyalase activity and 
antagonize the alloxan action.The present study suggested that the isolation 
of active constituents from ethanolic extract ofHaldina cordifolialeaf and 
characterize the compounds by using preliminary phytochemical studies and 
LCMS instrument used to isolate the compounds like Quercetin and 
Kaemferol were confirmed by confirmatory chemical tests. 
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